{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:08:00Z","timestamp":1790356080732,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:00:00Z","timestamp":1784332800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:00:00Z","timestamp":1784332800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s10147-026-03140-w","type":"journal-article","created":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T14:01:07Z","timestamp":1784383267000},"page":"2353-2362","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk of second primary malignancies after bladder cancer diagnosed at a young age: a SEER population-based analysis"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-1968-7556","authenticated-orcid":false,"given":"Etan","family":"Eigner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Fazaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ameer","family":"Nsair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Atallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilad E.","family":"Amiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azik","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamil","family":"Malshy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,18]]},"reference":[{"issue":"3","key":"3140_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"3140_CR2","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/iju.13376","volume":"24","author":"J Miyazaki","year":"2017","unstructured":"Miyazaki J, Nishiyama H (2017) Epidemiology of urothelial carcinoma. Int J Urol 24(10):730\u2013734","journal-title":"Int J Urol"},{"issue":"1","key":"3140_CR3","first-page":"7","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A (2020) Cancer statistics, 2020. CA Cancer J Clin 70(1):7\u201330","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"3140_CR4","doi-asserted-by":"publisher","first-page":"934e11","DOI":"10.1016\/j.urolonc.2020.06.009","volume":"38","author":"C Palumbo","year":"2020","unstructured":"Palumbo C, Pecoraro A, Rosiello G, Luzzago S, Deuker M, Stolzenbach F et al (2020) Bladder cancer incidence rates and trends in young adults aged 20\u201339 years. Urologic Oncology: Seminars Original Investigations 38(12):934e11\u2013934e19","journal-title":"Urologic Oncology: Seminars Original Investigations"},{"issue":"5","key":"3140_CR5","doi-asserted-by":"publisher","first-page":"463","DOI":"10.56434\/j.arch.esp.urol.20247705.65","volume":"77","author":"S P\u00e9rez Gonz\u00e1lez","year":"2024","unstructured":"P\u00e9rez Gonz\u00e1lez S, Heredia-Soto V, Gir\u00f3n de Francisco M, P\u00e9rez-Fernandez E, Casans-Franc\u00e9s R, Del Rosario Rodr\u00edguez V et al (2024) Clinical, Pathological Characteristics and Progression of Urothelial Bladder Cancer in Young Adult Patients. Our Experience and Literature Review. Arch Esp Urol 77(5):463","journal-title":"Arch Esp Urol"},{"issue":"11","key":"3140_CR6","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1158\/1055-9965.EPI-06-0414","volume":"15","author":"LB Travis","year":"2006","unstructured":"Travis LB (2006) The Epidemiology of Second Primary Cancers. Cancer Epidemiology. Biomarkers Prev 15(11):2020\u20132026","journal-title":"Biomarkers Prev"},{"key":"3140_CR7","unstructured":"National Cancer Institute Second primary cancers among cancer survivors [Internet]. https:\/\/dceg.cancer.gov\/research\/what-we-study\/second-cancers"},{"key":"3140_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/bco2.70021","author":"C H\u00e4ggstr\u00f6m","year":"2025","unstructured":"H\u00e4ggstr\u00f6m C, Hagberg O, Holmberg L, Hosseini A, Jerlstr\u00f6m T, Str\u00f6ck V et al (2025) Risk of upper urinary tract urothelial carcinoma after primary non-muscle\u2010invasive urinary bladder cancer: A nationwide population\u2010based cohort study. BJUI Compass. https:\/\/doi.org\/10.1002\/bco2.70021","journal-title":"BJUI Compass"},{"issue":"18","key":"3140_CR9","doi-asserted-by":"publisher","first-page":"6512","DOI":"10.1158\/1078-0432.CCR-05-0891","volume":"11","author":"TD Jones","year":"2005","unstructured":"Jones TD, Wang M, Eble JN, MacLennan GT, Lopez-Beltran A, Zhang S et al (2005) Molecular Evidence Supporting Field Effect in Urothelial Carcinogenesis. Clin Cancer Res 11(18):6512\u20136519","journal-title":"Clin Cancer Res"},{"key":"3140_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-025-01235-7","author":"X Zhang","year":"2025","unstructured":"Zhang X, Yang F, Tao J, Wang K, Xu K, Liu T et al (2025) Comprehensive genomic insights into the genetic causality and comorbidity in urological cancers. NPJ Precis Oncol. https:\/\/doi.org\/10.1038\/s41698-025-01235-7","journal-title":"NPJ Precis Oncol"},{"issue":"9","key":"3140_CR11","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41585-023-00761-y","volume":"20","author":"J Chen","year":"2023","unstructured":"Chen J, Huang C-P, Quan C, Zu X, Ou Z, Tsai Y-C et al (2023) The androgen receptor in bladder cancer. Nat Rev Urol 20(9):560\u2013574","journal-title":"Nat Rev Urol"},{"issue":"16","key":"3140_CR12","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1002\/pros.70035","volume":"85","author":"K Xu","year":"2025","unstructured":"Xu K, Khan A, Evancho P, Chu M, Riggin A, Huang H et al (2025) Analysis of the Increased Incidence of Aggressive Prostate Cancer After Prior Testicular Cancer. Prostate 85(16):1481\u20131487","journal-title":"Prostate"},{"issue":"25","key":"3140_CR13","doi-asserted-by":"publisher","first-page":"17420","DOI":"10.18632\/oncotarget.24724","volume":"9","author":"L Jacob","year":"2018","unstructured":"Jacob L, Freyn M, Kalder M, Dinas K, Kostev K (2018) Impact of tobacco smoking on the risk of developing 25 different cancers in the UK: a retrospective study of 422,010 patients followed for up to 30 years. Oncotarget 9(25):17420\u201317429","journal-title":"Oncotarget"},{"issue":"2","key":"3140_CR14","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3390\/epidemiologia4020012","volume":"4","author":"S Tancredi","year":"2023","unstructured":"Tancredi S, Cullati S, Chiolero A (2023) Screening and Surveillance Bias in Cancer. Epidemiologia 4(2):117\u2013120","journal-title":"Epidemiologia"},{"key":"3140_CR15","unstructured":"Chavarriaga JBCANTT (2025) : Tracking and Tackling an Increasing Trend in Young-Onset Bladder\/Urothelial Cancer [Internet]. UroToday. 2025"},{"issue":"17","key":"3140_CR16","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1001\/jama.2011.1592","volume":"306","author":"EA Engels","year":"2011","unstructured":"Engels EA, Pfeiffer RM, Fraumeni JF, Kasiske BL, Israni AK, Snyder JJ et al (2011) Spectrum of Cancer Risk Among US Solid Organ Transplant Recipients. JAMA 306(17):1891","journal-title":"JAMA"},{"issue":"1","key":"3140_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/medsci8010015","volume":"8","author":"K Saginala","year":"2020","unstructured":"Saginala K, Barsouk A, Aluru JS, Rawla P, Padala SA, Barsouk A (2020) Epidemiology of Bladder Cancer. Med Sci 8(1):15","journal-title":"Med Sci"},{"issue":"6","key":"3140_CR18","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.21037\/tau-20-1333","volume":"10","author":"A Nayak","year":"2021","unstructured":"Nayak A, Cresswell J, Mariappan P (2021) Quality of life in patients undergoing surveillance for non-muscle invasive bladder cancer\u2014a systematic review. Transl Androl Urol 10(6):2737\u20132749","journal-title":"Transl Androl Urol"},{"issue":"24","key":"3140_CR19","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1001\/jama.2020.23130","volume":"324","author":"H Sung","year":"2020","unstructured":"Sung H, Hyun N, Leach CR, Yabroff KR, Jemal A (2020) Association of First Primary Cancer With Risk of Subsequent Primary Cancer Among Survivors of Adult-Onset Cancers in the United States. JAMA 324(24):2521","journal-title":"JAMA"},{"issue":"1","key":"3140_CR20","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/cncr.29685","volume":"122","author":"JS Lee","year":"2016","unstructured":"Lee JS, DuBois SG, Coccia PF, Bleyer A, Olin RL, Goldsby RE (2016) Increased risk of second malignant neoplasms in adolescents and young adults with cancer. Cancer 122(1):116\u2013123","journal-title":"Cancer"},{"issue":"1","key":"3140_CR21","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s10238-024-01502-0","volume":"24","author":"Y Guo","year":"2024","unstructured":"Guo Y, Zhang Y, Mao S, Zhang W, Yang F, Wang R et al (2024) Risk of subsequent primary cancers in bladder cancer survivors. Clin Exp Med 24(1):247","journal-title":"Clin Exp Med"},{"key":"3140_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/bjs\/znad377","author":"X Wang","year":"2024","unstructured":"Wang X, Zeng M, Ju X, Lin A, Zhou C, Shen J et al (2024) Correlation between second and first primary cancer: systematic review and meta-analysis of 9 million cancer patients. Br J Surg. https:\/\/doi.org\/10.1093\/bjs\/znad377","journal-title":"Br J Surg"},{"issue":"1","key":"3140_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/jnci\/djj001","volume":"98","author":"LB Travis","year":"2006","unstructured":"Travis LB, Rabkin CS, Brown LM, Allan JM, Alter BP, Ambrosone CB et al (2006) Cancer Survivorship\u2014Genetic Susceptibility and Second Primary Cancers: Research Strategies and Recommendations. JNCI: J Natl Cancer Inst 98(1):15\u201325","journal-title":"JNCI: J Natl Cancer Inst"},{"issue":"2","key":"3140_CR24","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.eururo.2012.07.047","volume":"63","author":"SC Skeldon","year":"2013","unstructured":"Skeldon SC, Semotiuk K, Aronson M, Holter S, Gallinger S, Pollett A et al (2013) Patients with Lynch Syndrome Mismatch Repair Gene Mutations Are at Higher Risk for Not Only Upper Tract Urothelial Cancer but Also Bladder Cancer. Eur Urol 63(2):379\u2013385","journal-title":"Eur Urol"},{"issue":"10","key":"3140_CR25","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1056\/NEJMra012242","volume":"348","author":"HT Lynch","year":"2003","unstructured":"Lynch HT, de la Chapelle A (2003) Hereditary Colorectal Cancer. N Engl J Med 348(10):919\u2013932","journal-title":"N Engl J Med"},{"issue":"2","key":"3140_CR26","first-page":"75","volume":"62","author":"MS Linet","year":"2012","unstructured":"Linet MS, Slovis TL, Miller DL, Kleinerman R, Lee C, Rajaraman P et al (2012) Cancer risks associated with external radiation from diagnostic imaging procedures. CA Cancer J Clin 62(2):75\u2013100","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"3140_CR27","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1001\/jama.2011.1142","volume":"306","author":"ND Freedman","year":"2011","unstructured":"Freedman ND (2011) Association Between Smoking and Risk of Bladder Cancer Among Men and Women. JAMA 306(7):737","journal-title":"JAMA"},{"issue":"1","key":"3140_CR28","doi-asserted-by":"publisher","first-page":"45","DOI":"10.5114\/wo.2021.103829","volume":"25","author":"K Chaitanya Thandra","year":"2021","unstructured":"Chaitanya Thandra K, Barsouk A, Saginala K, Sukumar Aluru J, Barsouk A (2021) Epidemiology of lung cancer. Wsp\u00f3\u0142czesna Onkologia 25(1):45\u201352","journal-title":"Wsp\u00f3\u0142czesna Onkologia"},{"issue":"12","key":"3140_CR29","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.14309\/ajg.0000000000000803","volume":"115","author":"E Botteri","year":"2020","unstructured":"Botteri E, Borroni E, Sloan EK, Bagnardi V, Bosetti C, Peveri G et al (2020) Smoking and Colorectal Cancer Risk, Overall and by Molecular Subtypes: A Meta-Analysis. Am J Gastroenterol 115(12):1940\u20131949","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"3140_CR30","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1093\/jjco\/hyw027","volume":"46","author":"YN Koyanagi","year":"2016","unstructured":"Koyanagi YN, Matsuo K, Ito H, Wakai K, Nagata C, Nakayama T et al (2016) Cigarette smoking and the risk of head and neck cancer in the Japanese population: a systematic review and meta-analysis. Jpn J Clin Oncol 46(6):580\u2013595","journal-title":"Jpn J Clin Oncol"},{"issue":"6","key":"3140_CR31","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41568-019-0142-8","volume":"19","author":"S Srivastava","year":"2019","unstructured":"Srivastava S, Koay EJ, Borowsky AD, De Marzo AM, Ghosh S, Wagner PD et al (2019) Cancer overdiagnosis: a biological challenge and clinical dilemma. Nat Rev Cancer 19(6):349\u2013358","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"3140_CR32","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1097\/JU.0000000000003846","volume":"211","author":"JM Holzbeierlein","year":"2024","unstructured":"Holzbeierlein JM, Bixler BR, Buckley DI, Chang SS, Holmes R, James AC et al (2024) Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA\/SUO Guideline: 2024 Amendment. J Urol 211(4):533\u2013538","journal-title":"J Urol"},{"issue":"1","key":"3140_CR33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.juro.2015.02.081","volume":"194","author":"M Mork","year":"2015","unstructured":"Mork M, Hubosky SG, Roupr\u00eat M, Margulis V, Raman J, Lotan Y et al (2015) Lynch Syndrome: A Primer for Urologists and Panel Recommendations. J Urol 194(1):21\u201329","journal-title":"J Urol"},{"issue":"2","key":"3140_CR34","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/JU.0000000000001911","volume":"206","author":"SC Campbell","year":"2021","unstructured":"Campbell SC, Clark PE, Chang SS, Karam JA, Souter L, Uzzo RG (2021) Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-Up: AUA Guideline: Part I. J Urol 206(2):199\u2013208","journal-title":"J Urol"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-026-03140-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-026-03140-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-026-03140-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:49:57Z","timestamp":1790354997000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-026-03140-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,18]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["3140"],"URL":"https:\/\/doi.org\/10.1007\/s10147-026-03140-w","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,18]]},"assertion":[{"value":"24 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study used publicly available, de-identified data from the Surveillance, Epidemiology, and End Results (SEER) program and did not involve identifiable human subjects; therefore, institutional review board approval and informed consent were not required. The study was conducted in accordance with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}